Business
The Lawsuit against ViaDerma, Inc. has been Dismissed in US District Federal Court as the Company Vigorously Defends its Patents, Product Line and its Shareholders
The Lawsuit against ViaDerma, Inc. has been Dismissed in US District Federal Court as the Company Vigorously Defends its Patents, Product Line and its Shareholders.
About this update from Viaderma, Inc.
[{"type":"text","content":"\nThe Lawsuit against ViaDerma, Inc. has been Dismissed in US District Federal Court as the Company Vigorously Defends its Patents, Product Line and its Shareholders\n\nThe Lawsuit against ViaDerma, Inc. has been Dismissed in US District Federal Court as the Company Vigorously Defends its Patents, Product Line and its Shareholders\n\n\nThe Company has been successful as the Lawsuit filed by Steven Keough or OPD HOLDINGS, LLC, and KASTEN, INC., Plaintiffs, in South Dakota has been Dismissed without Prejudice; The Company continues to evaluate its own claims against the Plaintiffs & Keough\n\n LOS ANGELES, CA--(Marketwired - February 06, 2018) - ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the Company's legal counsel, Austin Legal Group, has been successful in having the complaint filed by Steven J. Keough in a South Dakota Federal Court, dismissed without prejudice. The complaint alleged certain technical issues dating back to 2011, which the Company believes have been addressed and the Judge dismissed the case. The Company has filed provisional patents on several products, and their pending status has already gone through a screening process by the USPTO. The Company's President, Dr. Christopher Otiko, stated, \"the Company's legal counsel has vigorously defended this civil legal action to protect our shareholders and the Company's patent pending product line. The Company will continue to aggressively defend any legal action that will affect the progress ViaDerma, Inc. has made through its innovation, hard work and sacrifice. The Company continues to move ahead with its aggressive sales growth goals and new product development plans for 2018 and beyond!\"About ViaDerma, Inc.ViaDerma, Inc. (OTC PINK: VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. ViaDerma's products use an innovative transdermal delivery method that allows for application of active ingredients in a topical form. This patent-pending dual carrier transdermal technology may be applied in products within the medical and cosmetic markets. Also, a provisional patent application using t...